After years of sparring, the Biden administration and Gilead Sciences have settled a contentious lawsuit over patents for a ...

An international group of experts proposes two new categories of disease: preclinical and clinical obesity and the FDA ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

In a live taping of "The Readout LOUD" at #JPM25, Eli Lilly CEO Dave Ricks talks Trump, Medicare's drug price negotiation, ...

Lilly’s decision to offer vials has also been seen as its way to combat the rise in compounding. Patients have been turning ...

Officials who oversee an international treaty governing endangered species recommended suspending shipments of long-tailed ...

"We’re in very different place," the CEO of Editas says, citing the CRISPR pioneer's plans to get its first treatments into ...

Eli Lilly CEO said he believed the company could find “significant common cause” with the Trump administration, even if there ...

The FDA has banned a red food dye that has long been on the enemies list of consumer groups, as well as the designated next ...

A proposed FDA rule would set nicotine levels on tobacco products at less than half the current average and could save ...

The gas xenon, like the other noble, or inert, gases, is known for doing very little. The class of elements, because of its ...

Front-of-package labels have spurred companies in other countries to cut sugars and salt. The FDA wants to follow suit here.